Acquired toxoplasmosis during pregnancy at the instituto materno-infantil, bogotá

The frequency of acquired toxoplasmosis during pregnancy in Bogotá is not known exactly. The Instituto Materno Infantil-IMI is a referral care center for pregnant women of low incomes and obstetrical risk in Bogotá. This study was undertaken to determine the frequency of mothers with serological mar...

Full description

Autores:
Barrera, Ana M.
Castiblanco, Pablo
Gómez M., Jorge E.
López, Myriam C.
Ruiz, Ariel
Moncada, Ligia
Reyes, Patricia
Corredor, Augusto
Tipo de recurso:
Article of journal
Fecha de publicación:
2002
Institución:
Universidad Nacional de Colombia
Repositorio:
Universidad Nacional de Colombia
Idioma:
spa
OAI Identifier:
oai:repositorio.unal.edu.co:unal/31931
Acceso en línea:
https://repositorio.unal.edu.co/handle/unal/31931
http://bdigital.unal.edu.co/22011/
Palabra clave:
Toxoplasmosis congénita
diagnóstico
epidemiología
Toxoplasmosis
congenital
diagnosis
epidemiology
Rights
openAccess
License
Atribución-NoComercial 4.0 Internacional
Description
Summary:The frequency of acquired toxoplasmosis during pregnancy in Bogotá is not known exactly. The Instituto Materno Infantil-IMI is a referral care center for pregnant women of low incomes and obstetrical risk in Bogotá. This study was undertaken to determine the frequency of mothers with serological markers of recent infection (anti-Toxoplasma IgM and IgA) indicating a risk for congenital transmission and thus estimating its magnitude at IMI. We studied 637 pregnant women attended at the prenatal consultation clinic at the IMI. Serum samples from the mothers were obtained during July to December 1998 and were studied using Immunofluorescence Antibody Technique (IFAT) for specific anti-Toxoplasma IgG antibodies. In addition, specific anti-T. gondii IgM and IgA antibodies were investigated in patients with high titers in IFAT-IgG (≥1:1024). 301 samples were found to be positive in IFAT-IgG (47%). ISAgA IgM and IgA tests were performed in 92 patients with IFAT-IgG titers ≥1:1024. In 14 patients both the IgM and the IgA test were positive, thus 2,2% of patients have recently acquired toxoplasmosis in this group of people. These results are in contrast with previous results in pregnant women from Bogotá and highlight the need for specific control programs to prevent congenital toxoplasmosis.